Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4213473
Max Phase: Preclinical
Molecular Formula: C55H91N5O15
Molecular Weight: 1062.35
Molecule Type: Small molecule
Associated Items:
ID: ALA4213473
Max Phase: Preclinical
Molecular Formula: C55H91N5O15
Molecular Weight: 1062.35
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)Cc3ccc(-c4cn(CCCCCCCCCC(=O)NO)nn4)cc3)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
Standard InChI: InChI=1S/C55H91N5O15/c1-13-42-55(10,68)48(64)34(4)45(62)32(2)28-53(8,67)50(35(5)47(36(6)51(66)73-42)74-44-29-54(9,70-12)49(65)37(7)72-44)75-52-46(63)41(27-33(3)71-52)59(11)30-38-22-24-39(25-23-38)40-31-60(58-56-40)26-20-18-16-14-15-17-19-21-43(61)57-69/h22-25,31-37,41-42,44,46-50,52,63-65,67-69H,13-21,26-30H2,1-12H3,(H,57,61)/t32-,33-,34+,35+,36-,37+,41+,42-,44+,46-,47+,48-,49+,50-,52+,53-,54-,55-/m1/s1
Standard InChI Key: JRGIPAXSDZGUBN-IPBZGWQPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1062.35 | Molecular Weight (Monoisotopic): 1061.6512 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Hailu GS, Robaa D, Forgione M, Sippl W, Rotili D, Mai A.. (2017) Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives., 60 (12): [PMID:28241112] [10.1021/acs.jmedchem.6b01595] |
Source(1):